|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000674920
|
ATF4
|
NA
|
NA
|
pancreatic adenocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000674920
|
ATF4
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000674920
|
ATF4
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000674920
|
ATF4
|
DB14472
|
Insulin-like growth factor II
|
pancreatic cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000674920
|
ATF4
|
NA
|
BTdCPU
|
multiple myeloma
|
down-regulated
|
validated
|
more...
|
|
ENST00000674920
|
ATF4
|
DB00877
|
Sirolimus
|
multiple myeloma
|
down-regulated
|
validated
|
more...
|
|
ENST00000674920
|
ATF4
|
NA
|
Huganqingzhi tablets
|
non alcoholic fatty liver disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000674920
|
ATF4
|
DB14844
|
Dordaviprone
|
medullary thyroid carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000674920
|
ATF4
|
NA
|
GW3965
|
gastric cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000674920
|
ATF4
|
DB02546 (EXPT02902)
|
Vorinostat (SAHA)
|
glioma
|
down-regulated
|
validated
|
more...
|